Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment
J Rheumatol
.
2024 Nov 1;51(11):1051-1053.
doi: 10.3899/jrheum.2024-0900.
Authors
Romina Estefanía Nieto
1
,
Graciela S Alarcón
2
,
Laurent Arnaud
3
,
Guillermo Javier Pons-Estel
4
Affiliations
1
R.E. Nieto, MD, G.J. Pons-Estel, MD, PhD, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Grupo Oroño, Rosario, Argentina.
2
G.S. Alarcón, MD, MPH, The University of Alabama at Birmingham, Birmingham, Alabama, USA, and Universidad Peruana Cayetano Heredia, Lima, Peru.
3
L. Arnaud, MD, PhD, Department of Rheumatology, National Reference Center for Autoimmune Diseases (RESO), INSERM UMR-S 1109, Strasbourg, France.
4
R.E. Nieto, MD, G.J. Pons-Estel, MD, PhD, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Grupo Oroño, Rosario, Argentina;
[email protected]
.
PMID:
39353646
DOI:
10.3899/jrheum.2024-0900
No abstract available
Publication types
Editorial